Brendan Smith

Insider Reports History

Location
Lexington, MA
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brendan Smith:

Company Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Chief Financial Officer Common Shares 5,072 $317,015 $62.50 21 Feb 2023 Direct
CRISPR Therapeutics AG Chief Financial Officer Restricted Stock Units 11,475 18 Feb 2023 Direct
Translate Bio, Inc. Chief Financial Officer Stcok Option (right to buy) 0 14 Sep 2021 Direct

Insider Reports Filed by Brendan Smith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRSP CRISPR Therapeutics AG 18 Feb 2023 3 -$67,178 4 Chief Financial Officer 22 Feb 2023, 16:41
CRSP CRISPR Therapeutics AG 14 Oct 2022 3 -$61,949 4 Chief Financial Officer 18 Oct 2022, 17:38
CRSP CRISPR Therapeutics AG 07 Oct 2022 1 $0 4 Chief Financial Officer 12 Oct 2022, 17:42
CRSP CRISPR Therapeutics AG 16 Aug 2022 1 $0 4 Chief Financial Officer 18 Aug 2022, 17:39
CRSP CRISPR Therapeutics AG 18 Feb 2022 2 $0 4 Chief Financial Officer 22 Feb 2022, 16:44
CRSP CRISPR Therapeutics AG 14 Oct 2021 2 $0 4 Chief Financial Officer 18 Oct 2021, 20:00
CRSP CRISPR Therapeutics AG 14 Oct 2021 0 $0 3 Chief Financial Officer 15 Oct 2021, 20:00
/report/000120919121056064-smith-brendan-2021-09-14 Translate Bio, Inc. 14 Sep 2021 1 $0 4 Chief Financial Officer 14 Sep 2021, 19:33